Ipratropium Bromide

Hyperkalemia, Acute Bronchitis, Pneumonia + 18 more
Treatment
6 FDA approvals
20 Active Studies for Ipratropium Bromide

What is Ipratropium Bromide

SalbutamolThe Generic name of this drug
Treatment SummaryIpratropium is an anticholinergic medication that is taken through inhalation. It was developed by Boehringer Ingelheim and was approved by the FDA in 1986 for individual use and 1996 for use in combination with albuterol. It works by producing a local effect but does not cause significant absorption into the body.
Proair HFAis the brand name
image of different drug pills on a surface
Ipratropium Bromide Overview & Background
Brand Name
Generic Name
First FDA Approval
How many FDA approvals?
Proair HFA
Salbutamol
1981
314

Approved as Treatment by the FDA

Salbutamol, also known as Proair HFA, is approved by the FDA for 6 uses like Bronchospasm and Bronchospasm, Exercise-Induced .
Bronchospasm
Bronchospasm, Exercise-Induced
Exercise-Induced Bronchospasm
Chronic Obstructive Pulmonary Disease
Used to treat Chronic Obstructive Pulmonary Disease (COPD) in combination with Ipratropium
Bronchodilator Agents
Used to treat need of more than one bronchodilator in combination with Ipratropium
prophylaxis of Bronchospasm

Effectiveness

How Ipratropium Bromide Affects PatientsIpratropium is a medication that helps to relax the muscles in your airways and makes it easier to breathe. It usually takes 1-2 hours for this medication to start working and its effects typically last between 4-6 hours. In clinical trials, ipratropium was found to help improve breathing and lung function in people with asthma. However, it is not known if taking ipratropium regularly or as a preventative measure is beneficial.
How Ipratropium Bromide works in the bodyIpratropium works by blocking the activity of acetylcholine in the airways, which prevents them from constricting. This effect allows the airways to stay relaxed and open, leading to bronchodilation and fewer secretions. At the cellular level, ipratroium stops the acetylcholine from contracting the muscle cells and narrowing the airways.

When to interrupt dosage

The prescribed dosage of Ipratropium Bromide is contingent upon the indicated condition, including Chronic Obstructive Pulmonary Disease (COPD), Asthma and Non-Allergic Rhinitis. The measure of dosage fluctuates, as per the administration approach noted in the table below.
Condition
Dosage
Administration
Emphysema
2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation
, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution, Solution - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet - Oral, Tablet, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Liquid - Intravenous, Intramuscular, Liquid - Intramuscular, Capsule, Capsule - Respiratory (inhalation), Liquid - Oral, Solution - Intramuscular, Spray, metered - Respiratory (inhalation), Spray, metered, Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Aerosol, spray, Aerosol, spray - Oral, Spray, Spray - Oral, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal
Hyperkalemia
2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation
, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution, Solution - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet - Oral, Tablet, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Liquid - Intravenous, Intramuscular, Liquid - Intramuscular, Capsule, Capsule - Respiratory (inhalation), Liquid - Oral, Solution - Intramuscular, Spray, metered - Respiratory (inhalation), Spray, metered, Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Aerosol, spray, Aerosol, spray - Oral, Spray, Spray - Oral, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal
Acute Bronchitis
2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation
, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution, Solution - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet - Oral, Tablet, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Liquid - Intravenous, Intramuscular, Liquid - Intramuscular, Capsule, Capsule - Respiratory (inhalation), Liquid - Oral, Solution - Intramuscular, Spray, metered - Respiratory (inhalation), Spray, metered, Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Aerosol, spray, Aerosol, spray - Oral, Spray, Spray - Oral, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal
Pneumonia
2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation
, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution, Solution - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet - Oral, Tablet, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Liquid - Intravenous, Intramuscular, Liquid - Intramuscular, Capsule, Capsule - Respiratory (inhalation), Liquid - Oral, Solution - Intramuscular, Spray, metered - Respiratory (inhalation), Spray, metered, Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Aerosol, spray, Aerosol, spray - Oral, Spray, Spray - Oral, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal
Asthma
2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation
, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution, Solution - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet - Oral, Tablet, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Liquid - Intravenous, Intramuscular, Liquid - Intramuscular, Capsule, Capsule - Respiratory (inhalation), Liquid - Oral, Solution - Intramuscular, Spray, metered - Respiratory (inhalation), Spray, metered, Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Aerosol, spray, Aerosol, spray - Oral, Spray, Spray - Oral, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal
Bronchospasm
2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation
, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution, Solution - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet - Oral, Tablet, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Liquid - Intravenous, Intramuscular, Liquid - Intramuscular, Capsule, Capsule - Respiratory (inhalation), Liquid - Oral, Solution - Intramuscular, Spray, metered - Respiratory (inhalation), Spray, metered, Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Aerosol, spray, Aerosol, spray - Oral, Spray, Spray - Oral, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal
prophylaxis of Bronchospasm
2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation
, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution, Solution - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet - Oral, Tablet, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Liquid - Intravenous, Intramuscular, Liquid - Intramuscular, Capsule, Capsule - Respiratory (inhalation), Liquid - Oral, Solution - Intramuscular, Spray, metered - Respiratory (inhalation), Spray, metered, Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Aerosol, spray, Aerosol, spray - Oral, Spray, Spray - Oral, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal
Wheezing
2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation
, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution, Solution - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet - Oral, Tablet, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Liquid - Intravenous, Intramuscular, Liquid - Intramuscular, Capsule, Capsule - Respiratory (inhalation), Liquid - Oral, Solution - Intramuscular, Spray, metered - Respiratory (inhalation), Spray, metered, Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Aerosol, spray, Aerosol, spray - Oral, Spray, Spray - Oral, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal
Respiratory Tract Infections
2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation
, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution, Solution - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet - Oral, Tablet, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Liquid - Intravenous, Intramuscular, Liquid - Intramuscular, Capsule, Capsule - Respiratory (inhalation), Liquid - Oral, Solution - Intramuscular, Spray, metered - Respiratory (inhalation), Spray, metered, Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Aerosol, spray, Aerosol, spray - Oral, Spray, Spray - Oral, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal
Influenza
2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation
, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution, Solution - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet - Oral, Tablet, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Liquid - Intravenous, Intramuscular, Liquid - Intramuscular, Capsule, Capsule - Respiratory (inhalation), Liquid - Oral, Solution - Intramuscular, Spray, metered - Respiratory (inhalation), Spray, metered, Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Aerosol, spray, Aerosol, spray - Oral, Spray, Spray - Oral, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal
Chronic Obstructive Pulmonary Disease
2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation
, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution, Solution - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet - Oral, Tablet, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Liquid - Intravenous, Intramuscular, Liquid - Intramuscular, Capsule, Capsule - Respiratory (inhalation), Liquid - Oral, Solution - Intramuscular, Spray, metered - Respiratory (inhalation), Spray, metered, Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Aerosol, spray, Aerosol, spray - Oral, Spray, Spray - Oral, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal
Bronchospasm, Exercise-Induced
2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation
, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution, Solution - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet - Oral, Tablet, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Liquid - Intravenous, Intramuscular, Liquid - Intramuscular, Capsule, Capsule - Respiratory (inhalation), Liquid - Oral, Solution - Intramuscular, Spray, metered - Respiratory (inhalation), Spray, metered, Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Aerosol, spray, Aerosol, spray - Oral, Spray, Spray - Oral, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal
Bronchodilation
2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation
, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution, Solution - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet - Oral, Tablet, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Liquid - Intravenous, Intramuscular, Liquid - Intramuscular, Capsule, Capsule - Respiratory (inhalation), Liquid - Oral, Solution - Intramuscular, Spray, metered - Respiratory (inhalation), Spray, metered, Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Aerosol, spray, Aerosol, spray - Oral, Spray, Spray - Oral, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal
Airway secretion clearance therapy
2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation
, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution, Solution - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet - Oral, Tablet, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Liquid - Intravenous, Intramuscular, Liquid - Intramuscular, Capsule, Capsule - Respiratory (inhalation), Liquid - Oral, Solution - Intramuscular, Spray, metered - Respiratory (inhalation), Spray, metered, Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Aerosol, spray, Aerosol, spray - Oral, Spray, Spray - Oral, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal
Bronchodilator Agents
2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation
, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution, Solution - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet - Oral, Tablet, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Liquid - Intravenous, Intramuscular, Liquid - Intramuscular, Capsule, Capsule - Respiratory (inhalation), Liquid - Oral, Solution - Intramuscular, Spray, metered - Respiratory (inhalation), Spray, metered, Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Aerosol, spray, Aerosol, spray - Oral, Spray, Spray - Oral, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal
Chronic Bronchitis
2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation
, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution, Solution - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet - Oral, Tablet, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Liquid - Intravenous, Intramuscular, Liquid - Intramuscular, Capsule, Capsule - Respiratory (inhalation), Liquid - Oral, Solution - Intramuscular, Spray, metered - Respiratory (inhalation), Spray, metered, Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Aerosol, spray, Aerosol, spray - Oral, Spray, Spray - Oral, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal
Exercise-Induced Bronchospasm
2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation
, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution, Solution - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet - Oral, Tablet, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Liquid - Intravenous, Intramuscular, Liquid - Intramuscular, Capsule, Capsule - Respiratory (inhalation), Liquid - Oral, Solution - Intramuscular, Spray, metered - Respiratory (inhalation), Spray, metered, Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Aerosol, spray, Aerosol, spray - Oral, Spray, Spray - Oral, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal
Asthma
2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation
, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution, Solution - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet - Oral, Tablet, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Liquid - Intravenous, Intramuscular, Liquid - Intramuscular, Capsule, Capsule - Respiratory (inhalation), Liquid - Oral, Solution - Intramuscular, Spray, metered - Respiratory (inhalation), Spray, metered, Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Aerosol, spray, Aerosol, spray - Oral, Spray, Spray - Oral, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal
Asthmatic Bronchitis
2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation
, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution, Solution - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet - Oral, Tablet, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Liquid - Intravenous, Intramuscular, Liquid - Intramuscular, Capsule, Capsule - Respiratory (inhalation), Liquid - Oral, Solution - Intramuscular, Spray, metered - Respiratory (inhalation), Spray, metered, Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Aerosol, spray, Aerosol, spray - Oral, Spray, Spray - Oral, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal
excess mucus or phlegm
2.0 mg/mL, , 2.5 mg/mL, 0.09 mg, 3.0 mg/mL, 2.0 mg, 4.0 mg, 8.0 mg, 0.75 mg/mL, 1.5 mg/mL, 25.0 mg/mL, 0.63 mg/mL, 1.25 mg/mL, 0.108 mg, 5.0 mg/mL, 2.4 mg, 0.045 mg, 3.0 mg, 0.4 mg, 0.2 mg, 0.1 mg, 0.05 %, 0.1 %, 0.2 %, 0.83 mg/mL, 0.12 mg, 4.8 mg, 0.00009 mg/mg, 1.0 mg/mL, 0.1 mg/dose, 0.5 mg/mL, 0.2 mg/pump actuation, 0.097 mg/pump actuation, 0.1 mg/pump actuation, 0.4 mg/mL, 0.25 mg/mL, 0.12 mg/pump actuation
, Oral, Syrup, Syrup - Oral, Respiratory (inhalation), Solution, Solution - Respiratory (inhalation), Aerosol, metered, Aerosol, metered - Respiratory (inhalation), Tablet - Oral, Tablet, Tablet, film coated, extended release, Tablet, film coated, extended release - Oral, Intrabronchial, Solution - Intrabronchial, Solution - Oral, Aerosol, metered - Oral, Occlusive dressing technique, Syrup - Occlusive dressing technique, Tablet, extended release, Tablet, extended release - Oral, Solution - Intravenous, Intravenous, Powder, Powder - Respiratory (inhalation), Liquid, Liquid - Respiratory (inhalation), Liquid - Intravenous, Intramuscular, Liquid - Intramuscular, Capsule, Capsule - Respiratory (inhalation), Liquid - Oral, Solution - Intramuscular, Spray, metered - Respiratory (inhalation), Spray, metered, Powder, metered, Powder, metered - Respiratory (inhalation), Inhalant, Inhalant - Respiratory (inhalation), Aerosol, spray, Aerosol, spray - Oral, Spray, Spray - Oral, Aerosol, metered - Intrabronchial, Nasal, Inhalant - Nasal, Inhalant - Oral, Solution - Nasal

Warnings

There are 20 known major drug interactions with Ipratropium Bromide.
Common Ipratropium Bromide Drug Interactions
Drug Name
Risk Level
Description
Hydroxyzine
Major
The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Hydroxyzine.
Mobocertinib
Major
The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Mobocertinib.
Ziprasidone
Major
The risk or severity of QTc prolongation can be increased when Salbutamol is combined with Ziprasidone.
1-benzylimidazole
Minor
The risk or severity of hypertension can be increased when Salbutamol is combined with 1-benzylimidazole.
2,5-Dimethoxy-4-ethylamphetamine
Minor
The risk or severity of hypertension can be increased when Salbutamol is combined with 2,5-Dimethoxy-4-ethylamphetamine.
Ipratropium Bromide Toxicity & Overdose RiskThe amount of ipratropium that would be toxic to mice after being taken orally is 1500mg/kg. It is unlikely to overdose on ipratropium due to its poor absorption rate. Ipratropium does not appear to cause cancer, birth defects, or genetic mutation. High doses of ipratropium have been linked to a decrease in fertility rates.
image of a doctor in a lab doing drug, clinical research

Ipratropium Bromide Novel Uses: Which Conditions Have a Clinical Trial Featuring Ipratropium Bromide?

282 active clinical trials are presently investigating the utility of Ipratropium Bromide in alleviating Asthma, Bronchospasm and Perennial Allergic Rhinitis (PAR).
Condition
Clinical Trials
Trial Phases
Chronic Obstructive Pulmonary Disease
102 Actively Recruiting
Phase 3, Not Applicable, Phase 1, Phase 2, Early Phase 1, Phase 4
Hyperkalemia
7 Actively Recruiting
Phase 3, Phase 4, Not Applicable, Phase 2
Bronchospasm
0 Actively Recruiting
Asthma
155 Actively Recruiting
Not Applicable, Phase 1, Phase 2, Phase 4, Early Phase 1, Phase 3
Pneumonia
63 Actively Recruiting
Phase 1, Phase 2, Not Applicable, Phase 3, Early Phase 1, Phase 4
Bronchodilator Agents
0 Actively Recruiting
Asthma
1 Actively Recruiting
Not Applicable
Bronchospasm, Exercise-Induced
0 Actively Recruiting
Wheezing
3 Actively Recruiting
Phase 2, Phase 3
Respiratory Tract Infections
1 Actively Recruiting
Phase 2
Airway secretion clearance therapy
0 Actively Recruiting
Exercise-Induced Bronchospasm
0 Actively Recruiting
Chronic Bronchitis
5 Actively Recruiting
Not Applicable, Phase 3, Phase 4
prophylaxis of Bronchospasm
0 Actively Recruiting
excess mucus or phlegm
0 Actively Recruiting
Bronchodilation
0 Actively Recruiting
Asthmatic Bronchitis
0 Actively Recruiting
Influenza
32 Actively Recruiting
Not Applicable, Phase 2, Phase 4, Phase 3, Phase 1
Acute Bronchitis
10 Actively Recruiting
Phase 4, Not Applicable, Phase 2, Phase 3
Bronchial Asthma
1 Actively Recruiting
Phase 3

Ipratropium Bromide Reviews: What are patients saying about Ipratropium Bromide?

5Patient Review
10/13/2014
Ipratropium Bromide for COPD with Chronic Bronchitis
This medication is a life-saver for those with emphysema and/or bronchitis. It quickly clears the lungs and stops coughing fits, allowing me to live a normal life for over eight years now.
5Patient Review
6/4/2022
Ipratropium Bromide for Prevention of Bronchospasm with Chronic Bronchitis
Ipratropium has completely changed my quality of life for the better. I had given up hope that anything could help me after 43 years and three surgeries, but this medication was a godsend.
5Patient Review
10/20/2014
Ipratropium Bromide for Chronic Obstructive Lung Disease
This medication, used in conjunction with Albuterol Sulfate, helped me very quickly. I was pleased with the results.
4.3Patient Review
9/23/2013
Ipratropium Bromide for Asthma
I get severe muscle cramps as a side effect, but the results for my asthma have been great.
4.3Patient Review
1/3/2015
Ipratropium Bromide for Chronic Obstructive Lung Disease
I use this in nebulizer form in combination with albuterol. I find that it works for a longer period of time than the rescue inhaler (albuterol only). However, I'm curious if there is a stronger combo available since the percentage of IB contained in one dose is so tiny (0.0173%).
4Patient Review
10/4/2010
Ipratropium Bromide for Chronic Obstructive Asthma
I used vials of 0.5 mg with 3 mg albuterol in a nebulizer. At first, this was really helpful for my bronchitis and asthma. However, after the third and fourth use I developed severe edema in my legs, ankles, and feet to the point where it hurt to walk. This is apparently a rare reaction, but it's serious enough that I don't want to use the rest of what I have.
4Patient Review
8/21/2013
Ipratropium Bromide for COPD with Chronic Bronchitis
I have a long-standing history of asthma, COPD and chronic bronchitis. So far, the combination of this treatment and 3.0 albuterol via nebulizer has been successful in keeping me out of urgent care centers.
4Patient Review
5/4/2012
Ipratropium Bromide for Chronic Obstructive Lung Disease
While this treatment has helped my breathing, it unfortunately also causes my nerves to feel frayed.
4Patient Review
8/22/2009
Ipratropium Bromide for Asthma
I use this inhaler medication in conjunction with Albuterol and it's been working great!
4Patient Review
1/12/2009
Ipratropium Bromide for Chronic Obstructive Asthma
I've just started this treatment, and I'm curious about what ingredients are in it (e.g., steroids).
3.7Patient Review
8/29/2015
Ipratropium Bromide for Asthma
The nebulizer with the Salbutamol Sulphate and ipratropium bromide inhalation solution has been helpful, but I have noticed some concerning side effects. For instance, it makes me dizzy and it's hard to concentrate.
3Patient Review
3/16/2013
Ipratropium Bromide for Asthma
This medicine caused me to cough when I inhaled it, making it difficult to fully take a breath. My mouth also felt really dry afterwards.
3Patient Review
1/21/2019
Ipratropium Bromide for Bronchospasm Prevention with COPD
I'm still getting used to this medication, but I am already seeing some improvement in my shortness of breath.
3Patient Review
7/27/2009
Ipratropium Bromide for Chronic Obstructive Lung Disease
Though this medication did not relieve my shortness of breath, it unfortunately seems to have made it worse. Is there sulfur in this medicine?
2.7Patient Review
5/9/2010
Ipratropium Bromide for Asthma
This medication does a fair job at relieving my asthma symptoms; however, it comes with the very unpleasant side-effect of causing painful leg cramps that last for days. I've tried drinking tonic water as my doctor recommended, but it doesn't help.
2.7Patient Review
9/15/2015
Ipratropium Bromide for Emphysema
My first time trying this, my breathing got worse. I tried blowing into ????? but saw only a slight improvement. Will try again later and see what happens.
image of drug pills surrounding a glass of water symbolizing drug consumption

Patient Q&A Section about ipratropium bromide

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What are the side effects of ipratropium bromide?

"The following are common symptoms of an ulcer: dizziness, nausea, heartburn, constipation, dry mouth, difficulty urinating, pain when urinating, and frequent need to urinate."

Answered by AI

Is Albuterol the same as ipratropium bromide?

"Both Albuterol and Ipratropium bromide work quickly to provide relief from severe symptoms and breathing difficulties. Ipratropium bromide is an anticholinergic medication, while albuterol is a short-acting beta2- adrenergic agonist."

Answered by AI

Is ipratropium bromide considered a steroid?

"Atrovent (ipratropium) is not a steroid. It is an anticholinergic, which is a type of medication that works differently than steroids to treat runny nose and allergies."

Answered by AI

What is a ipratropium bromide used for?

"Ipratropium is a medication that is used to help manage the symptoms of various lung diseases, such as asthma, bronchitis, and emphysema. It can also be used to help treat blockages in air flow and to prevent the worsening of chronic obstructive pulmonary disease (COPD)."

Answered by AI

Clinical Trials for Ipratropium Bromide

Have you considered Ipratropium Bromide clinical trials? We made a collection of clinical trials featuring Ipratropium Bromide, we think they might fit your search criteria.
Have you considered Ipratropium Bromide clinical trials? We made a collection of clinical trials featuring Ipratropium Bromide, we think they might fit your search criteria.
Have you considered Ipratropium Bromide clinical trials? We made a collection of clinical trials featuring Ipratropium Bromide, we think they might fit your search criteria.